
SoftWave holds FDA clearances tied to specific medical indications, including:
These are defined intended uses reviewed under U.S. regulatory standards.
FDA clearance establishes documented regulatory status — not generalized claims, but specific uses supported by formal submission and review.
That distinction determines how the device stands up to scrutiny in real clinical environments — including yours.
Regulatory clarity supports:
It allows you to focus on care instead of second-guessing compliance.
SoftWave is supported by documented regulatory and safety infrastructure.
For you, that means clearer compliance boundaries and greater confidence in the technology you bring into patient care.
For your patients, it reinforces trust that treatment is grounded in reviewed, verifiable standards.
This is engineered safety in real clinical practice.
Every device you introduce becomes part of your clinical accountability.
If questions arise — from patients, payers, hospital systems, or regulatory boards — you stand behind the decision to use it.
Devices without documented regulatory status create uncertainty.
Uncertainty increases exposure.
SoftWave’s clearances provide defined intended use and verified safety review before the device ever reaches your clinic.
That is protection built into the technology.
When a device lacks documented regulatory status, the burden of interpretation shifts to you. You must navigate safety boundaries, intended use, and compliance exposure without formal determination behind the device. SoftWave removes that guesswork by establishing it before the device ever enters your practice.